Apolipoprotein C-III can specifically bind to hepatic plasma membranes

Molecular and Cellular Biochemistry

Volumn 207, Issue 1-2, 2000, Pages 57-64

  Fang, Ding Z ^a   Liu, Bing W ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Apolipoprotein C III; Hepatic plasma membranes; Human; Mouse; Specific binding

Indexed keywords

APOLIPOPROTEIN C3; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MEMBRANE PROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; LIPOPROTEIN METABOLISM; LIVER CELL MEMBRANE; LIVER HOMOGENATE; MALE; MEMBRANE BINDING; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PROTEIN LIPID INTERACTION;

ANIMALIA;

EID: 0034047801     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007038129481     Document Type: Article

References (42)

1. Mahley RW, Innerarity TL: Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta 737: 197-222, 1983
2. Hiltunen TP, Yla-Herttuala S: Expression of lipoprotein receptors in atheroslerotic lesions. Atheroslerosis 137(suppl): s81-s88, 1998
3. Takahashi S, Kawarabayashi Y, Nakai T, Sakai J, Yamamoto T: Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 89: 9252-9256, 1992
4. Brown MS, Goldstein JL: A receptor mediated pathway for cholesterol homeostasis. Science 232: 34-47, 1986
5. Fielding JF, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 36: 211-228, 1995
6. Schonfeld G, Georges PI, Miller J, Reilly P, Witztum J: Apolipoprotein C-II and C-III levels in hyperlipoproteinemia. Metabolism 28: 1001-1009, 1979
7. Stocks J, Holdsworth G, Galton DJ: Hypertriglyceridaemia associated with an abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-III. Lancet ii: 667-671, 1979
8. Le N-A, Gibson JC, Ginsberg HN: Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: Implications for the regulation of the catabolism of these lipoproteins. J Lipid Res 29: 669-677, 1988
9. Malmendier CL, Lontie J-F, Delcroix C, Dubois DY, Magot T, De Roy L: Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration. Atherosclerosis 77: 139-149, 1989
10. Ginsberg HN, Le N-A, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown WV: Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI: Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 78: 1287-1295, 1986
11. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL: An apolipoprotein CIII haplotype protective against hyper-triglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci USA 90: 4562-4566, 1993
12. Rees A, Shoulders CC, Stocks J, Galton DJ, Baralle FE: DNA polymorphism adjacent to human apoprotein A-I gene: Relation to hypertriglyceridemia. Lancet i: 444-446, 1983
13. Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, Osada J: Targetted disruption of the apolipoprotein C-III gene in mice results in hypertriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem 269: 23610-23616, 1994
14. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL: Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249: 790-793, 1990
15. de Suva HV, Lauer SJ, Wang J, Simonet WS, Weisgraber KH, Mahley RW, Taylor JM: Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J Biol Chem 269: 2324-2335, 1994
16. Aalto-Set K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL: Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest 90: 1889-1900, 1992
17. Clavey V, Lestavel-Delattre S, Copin C, Bard JM, Fruchart JC: Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler Thromb Vase Biol 15: 963-971, 1995
18. Aalto-Set K, Weinstock PH, Bisgaier CL, Wu L, Smith JD, Breslow JL: Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apo C-III transgenic mice. J Lipid Res 37: 1802-1811, 1996
19. Ebara T, Ramakrishnan R, Steiner G, Shachter NS: Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E. J Clin Invest 99: 2672-2681, 1997
20. Jackson RL, Holdsworth G: Isolation and properties of human apolipoproteins C-I, C-II, and C-III. Meth Enzymol 128: 288-297, 1986
21. Kashyap ML, Srivastava LS, Hynd BA, Gartside PS, Perisutti G: Quantitation of human apolipoprotein CIII and its subspecies by radioimmnoassay and analytic isoectric focussing. J Lipid Res 22: 800-810, 1981
22. Hogeboom G: Fractionation of cell components of animal tissues. Meth Enzymol 1: 16-19, 1955
23. Neville MD: Isolation of an organ specific protein antigen from cell-surface membranes of rat liver. Biochim Biophys Acta 154: 540-552, 1968
24. Ray TK: A modified method for the isolation of the plasma membranes from rat liver. Biochim Biophys Acta 196: 1-9, 1970
25. Mahley R, Hui D, Innerarity T, Weisgraber K: Two independent lipoprotein receptors on hepatic membraness of dog, swine and man. J Clin Invest 68: 1197-1206, 1981
26. Hui D, Brecht W, Hall E, Friedman G, Innerarity T, Mahley R: Isolation and characterization of the apolipoprotein E receptors from canine and human liver. J Biol Chem 261: 4256-4267, 1986
27. Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK: The LDL-receptor-related protein, LRP, is an apolipoprotein E binding protein. Nature 341: 162-164, 1989
28. Kim DH, Iijima H, GotoK, Sakai J, Ishii H, Kim HJ, Suzuki H, Kondo H, Saeki S, Yamamoto T: Human apolipoprotein E receptor 2: a novel lipoprotein receptor family predominantly expressed in brain. J Biol Chem 272: 24761-24768, 1996
29. Suzuki J, Takahashi S, Oida K, Shimada A, Kohno M, Tamai T, Miyabo S, Yamamoto T, Nakai T: Lipid accumulation and foam cell formation in Chinese hamster ovary cells over-expressing very low density lipoprotein receptor. Biochem Biophys Res commun 206: 835-842, 1995
30. Frykman PK, Brown MS, Yamamoto T, Goldstein JL, Herz J: Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc Natl Acad Sci USA 92: 8453-8457, 1995
31. Wyne KL, Pathak PK, Seabra MC, Hobbs HH: Expresion of the VLDL receptor in endothelial cells. Arterioscler Thromb Vasc Biol 16: 407-415, 1996
32. Goldstein J, Brown MS: Binding and degradation of low density lipoproteins by cultured human fibroblast. J Biol Chem 249: 5153-5162, 1974
33. Goldstein J, Brown MS: Progress in understanding the LDL receptor and HMG-CoA reductase, two membranes proteins that regulate the plasma cholesterol. J Lipid Res 25: 1450-1461, 1984
34. Fernandez M, McNamara D: High density lipoprotein binding to guinea-pig hepatic membraness. Comparison of guinea-pig and human ligands. Biochim Biophys Acta 1042: 142-145, 1990
35. Oram J, Mendez A, Slotte J, Johnson T: High density lipoprotein apolipoproteins mediated removal of sterol from intracellular pools but not from plasma membraness of cholesterol-loaded fibroblasts. Aterioscler Throm Vasc Biol 11: 403-414, 1991
36. Acton S, Rigotti A, Landschultz KT, Xu S, Hobbs HH, Krieger M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518-520, 1996
37. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63: 601-637, 1994
38. Krieger M: The other side of scavenger receptors. Pattern recognition for host defense. Curr Opin Lipidology 8: 275-280, 1997
39. Fraser I, Hughes D, Gordon S: Divalent cation-independent macrophage adhension inhibited by monoclonal antibody to murine scavenger receptor. Nature 364: 343-346, 1993
40. Li H, Freeman MW, Libby P: Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 95: 122-133, 1995
41. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T: An endothelial receptor for oxidized low density lipoprotein. Nature 386: 73-77, 1997
42. Scheider Wj, Nimpf J, Bujo H: Novel members of the low density lipoprotein receptor superfamily and their potential roles in lipid metabolism. Curr Opin Lipidology 8: 315-319, 1997